NOW ENROLLING REMOTELY ACROSS THE UNITED STATES!
Call today for more information: 1-855-876-9997
Call today for more information: 1-855-876-9997
What is the Study of Tecovirimat for Mpox (STOMP)?
STOMP is a NIAID-funded clinical trial led by the ACTG to evaluate the efficacy of the antiviral tecovirimat, also know as TPOXX, for the treatment of Mpox.
Click here for more information about this study
Who is eligible to participate
in the study?
Adults and children of any age with Mpox are eligible to enroll in the trial.
Find a research site near you!Help us learn more about treating Mpox today!
More information on the trial can be found at
ClinicalTrials.gov
